Cumulative Doses of T-Cell Depleting Antibody and Cancer Risk after Kidney Transplantation

T-cell depleting antibody is associated with an increased risk of cancer after kidney transplantation, but a dose-dependent relationship has not been established. This study aimed to determine the association between cumulative doses of T-cell depleting antibody and the risk of cancer after kidney t...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jenny H. C., Wong, Germaine, Chapman, Jeremy R., Lim, Wai H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640502/
https://www.ncbi.nlm.nih.gov/pubmed/26555791
http://dx.doi.org/10.1371/journal.pone.0139479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640502/
https://www.ncbi.nlm.nih.gov/pubmed/26555791
http://dx.doi.org/10.1371/journal.pone.0139479

Ejemplares similares